Batiraxcept (AVB-S6-500)/Placebo in Combination With Paclitaxel in Patients With Platinum-Resistant Recurrent Ovarian Cancer

Clinical trial NCT04729608 · TERMINATED

Trial details

NCT number: NCT04729608
Sponsor: Aravive, Inc.
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Platinum-resistant Ovarian Cancer

Start date: 2021-04-22
Primary completion: 2023-08-04
Enrollment: 366

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.